# ATRA (Atara Biotherapeutics, Inc.) - SEC EDGAR Financial Statements

> Atara Biotherapeutics, Inc. reported $3.96M in revenue and a net loss of $14.61M for the trailing twelve months ended September 30, 2026 (down 64.6% year over year), with a -343.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/ATRA
- Markdown: https://convexityos.com/fundamentals/ATRA.md
- SEC CIK: 0001604464
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:50 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001604464&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $3.96M | -64.6% YoY |
| Operating Income | TTM | -$13.62M | -343.6% margin |
| Net Income | TTM | -$14.61M | -368.6% net margin |
| Diluted EPS | TTM | -$0.95 | Split-adjusted |
| Free Cash Flow | TTM | -$50.94M | -1284.7% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $9.92M | Total debt: $9.57M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $120.8M | $128.9M | $8.57M | $63.57M | -- | -- | -- | -- | -- | -- |
| Research & Development | $37.45M | $151.5M | $224.8M | $272.5M | $282.0M | $244.7M | $216.1M | $167.5M | $81.21M | $56.51M |
| Total Operating Expenses | -- | -- | -- | $344.1M | $360.8M | $309.1M | $295.7M | $237.1M | $121.5M | $81.24M |
| **Operating Income** | $35.86M | -$83.44M | -$276.0M | -$280.5M | -$340.5M | -$309.1M | -$295.7M | -$237.1M | -$121.5M | -$81.24M |
| **EBITDA** | $37.98M | -$78.39M | -$271.2M | -$274.9M | -$331.1M | -$300.7M | -$288.6M | -$233.4M | -$120.6M | -$80.86M |
| Interest Income | $683K | $2.11M | $5.43M | $3.06M | -- | -- | -- | -- | -- | -- |
| Interest Expense | $3.79M | $4.62M | $5.29M | $373K | -- | -- | -- | -- | -- | -- |
| Income Before Tax | $32.72M | -$85.42M | -$276.1M | -$228.3M | -$340.1M | -$306.6M | -$291.0M | -$230.7M | -$119.5M | -$79.04M |
| Income Tax Expense | $31K | -$12K | $15K | $12K | $46K | $15K | $12K | -$44K | -$14K | $10K |
| **Net Income** | $32.69M | -$85.40M | -$276.1M | -$228.3M | -$340.1M | -$306.6M | -$291.0M | -$230.7M | -$119.5M | -$79.05M |
| Basic EPS | $2.61 | -$11.41 | -$65.19 | -$56.00 | -$90.75 | -$103.75 | -$141.75 | -$131.75 | -$100.00 | -$68.75 |
| **Diluted EPS** | $2.57 | -$11.41 | -$65.19 | -$56.00 | -$90.75 | -$103.75 | -$141.75 | -$131.75 | -$100.00 | -$68.75 |
| Basic Shares Outstanding | 12.5M | 7.5M | 4.2M | 4.1M | 3.7M | 3.0M | 2.1M | 1.8M | 1.2M | 1.1M |
| Diluted Shares Outstanding | 12.7M | 7.5M | 4.2M | 4.1M | 3.7M | 3.0M | 2.1M | 1.8M | 1.2M | 1.1M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.22M | $630K | $516K | $1.59M | $3.45M | $17.57M | $98.15M | $32.75M |
| Cost of Revenue | $265K | -- | -- | -- | $115K | -- | -- | -- |
| **Gross Profit** | $959K | -- | -- | -- | $3.34M | -- | -- | -- |
| Research & Development | $1.10M | $1.34M | $164K | -$223K | $2.92M | $7.31M | $27.43M | $28.72M |
| **Operating Income** | -$2.97M | -$4.72M | -$3.37M | -$2.56M | -$3.57M | $3.20M | $38.80M | -$12.20M |
| **EBITDA** | -$2.97M | -$4.71M | -$3.34M | -$2.51M | -$3.54M | $3.43M | $40.60M | -$11.10M |
| Interest Income | $68K | $78K | $54K | $100K | $204K | $143K | $236K | $597K |
| Interest Expense | -- | $191K | $830K | $894K | $909K | $972K | $1.02M | $1.02M |
| Income Before Tax | -$2.23M | -$4.83M | -$4.14M | -$3.41M | -$4.28M | $2.39M | $38.01M | -$12.71M |
| Income Tax Expense | $0 | $1.0K | $0 | $0 | $28K | $3.0K | $0 | -$19K |
| **Net Income** | -$2.23M | -$4.83M | -$4.14M | -$3.41M | -$4.30M | $2.39M | $38.01M | -$12.69M |
| Basic EPS | -$0.15 | -$0.32 | -$0.29 | -- | -$0.32 | $0.20 | $3.53 | -- |
| **Diluted EPS** | -$0.15 | -$0.32 | -$0.29 | -- | -$0.32 | $0.19 | $3.50 | -- |
| Basic Shares Outstanding | 15.3M | 15.0M | 14.1M | -- | 13.6M | 12.2M | 10.8M | -- |
| Diluted Shares Outstanding | 15.3M | 15.0M | 14.1M | -- | 13.6M | 12.3M | 10.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $8.48M | $25.03M | $25.84M | $92.94M | $106.1M | $200.4M | $74.32M | $60.70M | $79.22M | $47.97M |
| Short-Term Investments | $0 | $17.47M | $25.88M | $149.9M | $265.0M | $300.3M | $184.8M | $248.9M | $86.87M | $207.7M |
| **Cash & Short-Term Investments** | $8.50M | $42.50M | $51.73M | $242.8M | $371.1M | $500.7M | $259.1M | $309.6M | $166.1M | $255.7M |
| Accounts Receivable, Net | $1.25M | $1.48M | $34.11M | $40.22M | $986K | $1.25M | $0 | -- | -- | -- |
| Inventory | $0 | $10.65M | $9.71M | $1.59M | $0 | -- | -- | -- | -- | -- |
| Other Current Assets | $2.48M | $10.12M | $6.18M | $10.31M | $12.37M | -- | -- | -- | -- | -- |
| **Total Current Assets** | $12.21M | $64.89M | $101.9M | $295.1M | $384.6M | $523.3M | $273.0M | $321.5M | $172.2M | $260.6M |
| Property, Plant & Equipment, Net | $73K | $1.29M | $3.86M | $6.30M | $53.78M | $50.52M | $54.18M | $68.58M | $44.13M | $3.26M |
| Other Non-Current Assets | $886K | $3.10M | $4.84M | $7.02M | $2.37M | $827K | $567K | $574K | $260K | $102K |
| **Total Non-Current Assets** | $8.02M | $44.20M | $63.63M | $81.34M | $83.51M | $64.85M | $69.95M | $70.35M | $45.59M | $3.36M |
| **Total Assets** | $20.23M | $109.1M | $165.5M | $376.4M | $468.1M | $588.1M | $342.9M | $391.8M | $217.8M | $263.9M |
| Accounts Payable | $127K | $4.37M | $3.68M | $6.87M | $17.37M | $7.12M | $7.96M | $3.72M | $14.71M | $2.78M |
| Deferred Revenue (Current) | $716K | -- | $77.83M | -- | -- | $33.45M | -- | -- | -- | -- |
| Other Current Liabilities | $2.98M | $20.16M | $31.83M | $21.39M | $9.06M | $6.06M | $5.73M | $6.41M | $3.27M | $744K |
| **Total Current Liabilities** | $14.92M | $134.6M | $142.2M | $78.92M | $105.8M | $82.90M | $36.74M | $39.98M | $27.65M | $9.68M |
| Deferred Revenue (Non-Current) | -- | $0 | $37.56M | $77.00M | $55.71M | $27.80M | -- | -- | -- | -- |
| Other Non-Current Liabilities | $1.79M | $3.27M | $4.63M | $5.56M | $1.50M | $2.04M | $1.28M | $13.00M | -- | -- |
| **Total Non-Current Liabilities** | $43.81M | $71.81M | $122.5M | $170.9M | $82.73M | $42.88M | $15.42M | $13.00M | $12.27M | $503K |
| **Total Liabilities** | $58.74M | $206.4M | $264.7M | $249.8M | $188.5M | $125.8M | $52.16M | $52.98M | $39.91M | $10.18M |
| **Total Debt (incl. Leases)** | $10.38M | $45.43M | $60.49M | $75.35M | $28.30M | $15.18M | $15.96M | $587K | -- | -- |
| Common Stock | $1.0K | $1.0K | $0 | $10K | $9.0K | $8.0K | $6.0K | $5.0K | $3.0K | $3.0K |
| Retained Earnings | -$2.02B | -$2.05B | -$1.97B | -$1.69B | -$1.46B | -$1.12B | -$818.0M | -$527.3M | -$296.6M | -$177.2M |
| Accumulated Other Comp. Income | $1.0K | $8.0K | -$204K | -$2.07M | -$368K | $296K | $220K | -$340K | -$151K | -$183K |
| **Total Stockholders' Equity** | -$38.50M | -$97.28M | $99.23M | $126.6M | $279.6M | $462.3M | $290.8M | $339.2M | $177.9M | $253.7M |
| Total Equity | -$38.50M | -$97.28M | $99.23M | $126.6M | $279.6M | $462.3M | $290.8M | $339.2M | $177.9M | $253.7M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.05M | $3.22M | $8.36M | $8.48M | $5.74M | $16.90M | $13.84M | $25.03M |
| Short-Term Investments | $5.86M | $6.65M | -- | $0 | $7.97M | $5.42M | $0 | $17.47M |
| **Cash & Short-Term Investments** | $9.90M | $9.90M | $8.36M | $8.50M | $13.71M | $22.32M | $13.84M | $42.50M |
| Accounts Receivable, Net | $691K | $318K | $0 | $1.25M | $1.91M | $0 | $8.88M | $1.48M |
| Inventory | -- | -- | -- | $0 | $0 | $0 | $0 | $10.65M |
| Other Current Assets | $705K | $3.34M | $3.81M | $2.48M | $2.81M | $2.45M | $4.32M | $10.12M |
| **Total Current Assets** | $11.31M | $13.53M | $12.17M | $12.21M | $18.43M | $24.77M | $27.18M | $64.89M |
| Property, Plant & Equipment, Net | $38K | $41K | $55K | $73K | $147K | $176K | $285K | $1.29M |
| Other Non-Current Assets | $762K | $765K | $890K | $886K | $881K | $927K | $2.84M | $3.10M |
| **Total Non-Current Assets** | $7.29M | $7.49M | $7.82M | $8.02M | $11.73M | $12.13M | $34.86M | $44.20M |
| **Total Assets** | $18.61M | $21.02M | $20.00M | $20.23M | $30.17M | $36.90M | $62.04M | $109.1M |
| Accounts Payable | $762K | $824K | $637K | $127K | $318K | $1.76M | $1.38M | $4.37M |
| Deferred Revenue (Current) | $513K | -- | -- | $716K | -- | -- | -- | -- |
| Other Current Liabilities | $3.69M | $3.46M | $2.94M | $2.98M | $4.65M | $7.67M | $24.14M | $20.16M |
| **Total Current Liabilities** | $6.57M | $6.85M | $5.64M | $14.92M | $18.06M | $14.56M | $47.89M | $134.6M |
| Deferred Revenue (Non-Current) | $0 | -- | -- | -- | -- | $0 | $0 | $0 |
| Other Non-Current Liabilities | $1.90M | $1.89M | $1.83M | $1.79M | $1.76M | $1.73M | $3.13M | $3.27M |
| **Total Non-Current Liabilities** | $49.94M | $51.17M | $51.66M | $43.81M | $48.74M | $57.38M | $69.22M | $71.81M |
| **Total Liabilities** | $56.51M | $58.02M | $57.31M | $58.74M | $66.80M | $71.94M | $117.1M | $206.4M |
| **Total Debt (incl. Leases)** | $9.57M | $9.88M | $10.09M | $10.38M | $16.96M | $17.67M | $41.94M | $45.43M |
| Common Stock | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained Earnings | -$2.03B | -$2.03B | -$2.03B | -$2.02B | -$2.02B | -$2.01B | -$2.02B | -$2.05B |
| Accumulated Other Comp. Income | -$1.0K | -$2.0K | $0 | $1.0K | $2.0K | $0 | $0 | $8.0K |
| **Total Stockholders' Equity** | -$37.90M | -$37.00M | -$37.31M | -$38.50M | -$36.63M | -$35.04M | -$55.07M | -$97.28M |
| Total Equity | -$37.90M | -$37.00M | -$37.31M | -$38.50M | -$36.63M | -$35.04M | -$55.07M | -$97.28M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $32.69M | -$85.40M | -$276.1M | -$228.3M | -$340.1M | -$306.6M | -$291.0M | -$230.7M | -$119.5M | -$79.05M |
| Depreciation & Amortization | $2.12M | $5.05M | $4.83M | $5.65M | $9.35M | $8.33M | $7.07M | $3.73M | $956K | $383K |
| Stock-Based Compensation | $9.75M | $27.00M | $45.39M | $53.84M | $53.87M | $51.35M | $51.70M | $33.82M | $23.10M | $16.78M |
| Change in Receivables | $229K | $32.63M | $6.11M | -$39.23M | $264K | -$1.25M | $0 | $0 | -- | -- |
| Change in Inventory | $10.65M | -$4.43M | -$8.12M | -$1.59M | $0 | $0 | -- | -- | -- | -- |
| Change in Payables | -$4.24M | $687K | -$3.13M | -$9.21M | $9.07M | -$815K | $4.21M | -$1.96M | $2.16M | $981K |
| **Operating Cash Flow** | -$50.94M | -$68.72M | -$193.0M | -$270.4M | -$220.5M | -$180.8M | -$235.6M | -$179.8M | -$87.50M | -$60.02M |
| Capital Expenditure | $0 | -$246K | -$1.22M | -$4.19M | -$10.58M | -$4.51M | -$5.73M | -$35.92M | -$20.23M | -$3.02M |
| **Free Cash Flow** | -$50.94M | -$68.96M | -$194.2M | -$274.6M | -$231.1M | -$185.3M | -$241.4M | -$215.7M | -$107.7M | -$63.05M |
| **Investing Cash Flow** | $18.15M | $8.62M | $123.9M | $203.0M | $22.26M | -$120.7M | $60.46M | -$196.3M | $99.91M | $83.74M |
| Common Stock Issued | $1.47M | $9.35M | $2.14M | $21.89M | $98.70M | $69.19M | $47.73M | $47.59M | $19.16M | $0 |
| **Financing Cash Flow** | $16.10M | $59.28M | $2.01M | $53.08M | $103.9M | $427.6M | $188.8M | $357.5M | $20.05M | $506K |
| **Net Change in Cash** | -$16.69M | -$811K | -$67.10M | -$14.39M | -$94.32M | $126.1M | $13.62M | -$18.52M | $31.25M | $24.22M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.23M | -$4.83M | -$4.14M | -$3.41M | -$4.30M | $2.39M | $38.01M | -$12.69M |
| Depreciation & Amortization | $3.0K | $14K | $29K | $49K | $36K | $236K | $1.79M | $1.10M |
| Stock-Based Compensation | $457K | $394K | $749K | $1.52M | $1.23M | $2.80M | $4.21M | $5.85M |
| Change in Receivables | -$373K | -$318K | $1.25M | $660K | -$1.91M | $8.88M | -$7.39M | -$147K |
| Change in Inventory | -- | $0 | $0 | $0 | $0 | $0 | $10.65M | -$160K |
| Change in Payables | -$62K | $187K | $510K | -$191K | -$983K | -$83K | -$2.98M | $2.22M |
| **Operating Cash Flow** | -$879K | -$3.34M | -$3.07M | -$5.70M | -$9.79M | -$7.32M | -$28.14M | -$24.47M |
| Capital Expenditure | -- | -- | -- | $0 | $0 | $0 | $0 | -$90K |
| **Free Cash Flow** | -- | -- | -- | -$5.70M | -$9.79M | -$7.32M | -$28.14M | -$24.56M |
| **Investing Cash Flow** | $833K | -$6.63M | $0 | $8.44M | -$2.42M | -$5.07M | $17.20M | $3.38M |
| Common Stock Issued | $880K | $4.83M | $2.95M | -$25K | $1.50M | $0 | $0 | $0 |
| **Financing Cash Flow** | $880K | $4.83M | $2.95M | -$3.0K | $1.05M | $15.30M | -$250K | -$328K |
| **Net Change in Cash** | $834K | -$5.14M | -$122K | $2.74M | -$11.16M | $2.92M | -$11.19M | -$21.42M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | 29.7% | -64.7% | -3219.5% | -441.2% | -- | -- | -- | -- | -- | -- |
| **Net Profit Margin** | 27.1% | -66.2% | -3220.9% | -359.1% | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -- | -- | -278.3% | -180.3% | -121.6% | -66.3% | -100.1% | -68.0% | -67.2% | -31.2% |
| Return on Assets (ROA) | 161.5% | -78.3% | -166.8% | -60.7% | -72.7% | -52.1% | -84.8% | -58.9% | -54.9% | -30.0% |
| Current Ratio | 0.82x | 0.48x | 0.72x | 3.74x | 3.64x | 6.31x | 7.43x | 8.04x | 6.23x | 26.93x |
| Quick Ratio | 0.82x | 0.40x | 0.65x | 3.72x | 3.64x | 6.05x | 7.05x | 7.74x | 6.01x | 26.43x |
| Debt to Equity | -- | -- | 0.61x | 0.59x | 0.10x | 0.03x | 0.05x | 0.00x | -- | -- |
| **Revenue Growth (YoY)** | -6.3% | +1404.0% | -86.5% | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -343.6% | -229.7% | -27.3% | 29.7% | 17.3% | 4.3% | -6.7% | -64.7% |
| **Net Profit Margin** | -368.6% | -269.4% | -40.9% | 27.1% | 15.4% | 3.1% | -7.8% | -66.2% |
| Return on Assets (ROA) | -78.5% | -79.4% | -47.3% | 161.5% | 77.6% | 15.7% | -25.2% | -78.3% |
| Current Ratio | 1.72x | 1.98x | 2.16x | 0.82x | 1.02x | 1.70x | 0.57x | 0.48x |
| Quick Ratio | 1.61x | 1.49x | 1.48x | 0.82x | 1.02x | 1.70x | 0.57x | 0.40x |
| **Revenue Growth (YoY)** | -64.6% | -96.4% | -99.5% | -95.1% | -91.4% | -38.6% | +258.8% | +670.3% |
| Gross Profit Growth (YoY) | -71.3% | -- | -- | -- | -- | -- | -- | -- |
| Operating Income Growth (YoY) | -- | -247.6% | -108.7% | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -302.5% | -110.9% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -260.0% | -108.2% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
